MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Mitochondrial DNA(mtDNA)"

  • 2025 International Congress

    The Role of Mitochondrial DNA Haplogroups in determining the Age of Onset in Indian SCA2 Patients.

    A. Sonakar, C. Sharma, S. Reza, S. Pandey, M. Srivastava, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: To investigate the contribution of mitochondrial DNA (mtDNA) haplogroups to the age at onset (AO) of Spinocerebellar Ataxia type 2 (SCA2) in Indian patients,…
  • 2025 International Congress

    Quercetin Reduces mtDNA Release in PRKN-Deficient and Oxidatively Stressed SH-SY5Y Cells

    G. Agyeah, J. Ghelfi, L. Gallucci, K. Wasner, P. Antony, A. Rakovic, S. Pereira, A. Grünewald (Belval Esch-sur-Alzette, Luxembourg)

    Objective: This study investigates the role of Parkin deficiency in mitochondrial dysfunction and its contribution to mitochondrial DNA (mtDNA) release in Parkinson’s disease (PD). We…
  • 2025 International Congress

    CSF Mitochondrial DNA Indicates Body Composition and Energy Metabolism in Parkinson’s Disease.

    Y. Mizutani, T. Nakai, Y. Maeda, R. Ohdake, R. Nagao, S. Shima, K. Kawabata, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)

    Objective: This study aimed to elucidate the associations between cerebrospinal fluid (CSF) cell-free mitochondrial DNA (cf-mtDNA) levels and body composition, nutritional status, and metabolic biomarkers…
  • 2025 International Congress

    Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease

    N. Tran, X. Hou, M. Heckman, F. Fiesel, S. Koga, D. Dickson, W. Springer, O. Ross (Jacksonville, USA)

    Objective: To determine whether specific mitochondrial DNA (mtDNA) haplogroup(s) affect the level of p-S65-Ub as quantitative marker of mitochondrial damage in Lewy Body Disease. Background:…
  • 2025 International Congress

    Assessment of mitochondrial DNA copy number and common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2

    LE. Almaguer Mederos, D. Cuello Almarales, R. Aguilera Rodríguez, D. Almaguer Gotay, DO. Palenzuela Gardon, H. Camacho Rodríguez, A. Estupiñán Rodríguez, N. Canales Ochoa, S. Gispert, G. Auburger (Frankfurt am Main, Germany)

    Objective: Assessing the relevance of mtDNA copy number (mtDNAcn) and its common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2 (SCA2). Background:…
  • 2024 International Congress

    Parkinsonism Associated with Twinkle Gene Mutation

    C. Felin, B. Oliveira, Y. Borges, S. Trentin (Porto Alegre, Brazil)

    Objective: To describe a rare manifestation of Twinkle gene mutation causing not only progressive external ophthalmoplegia (PEO), but also parkinsonism. Background: PEO is one of…
  • 2024 International Congress

    A Patient with Overlapping SPG7 mutation and MERRF

    J. Patino, M. Koenig (Houston, USA)

    Objective: To describe the first case of concomitant spastic paraplegia type 7 (SPG7) and myoclonic epilepsy with ragged red fibers (MERRF) in a patient with…
  • 2023 International Congress

    Exome-wide and Mitogenome Sequencing of Indian Dystonia Patients

    I. Singh, A. Saini, R. Rajan, A. Srivastava (DELHI, India)

    Objective: To identify whole exome and mitochondrial genome mutation spectrum of dystonia in India and to establish clinical significance of mutations by phenotype-genotype correlation. Background:…
  • 2023 International Congress

    Association of Early and late age of onset with Mitochondrial DNA haplogroup in Indian Spinocerebellar Ataxia type- 2 patients.

    A. Sonakar, M. Srivastava, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: To explore the role of mtHaplogroups in early and late onset SCA2 patients. Background: An unstable expansion of a CAG tract in the ATXN2…
  • 2023 International Congress

    Metabolic modulation of mitochondrial DNA release in cellular models of Parkin-associated Parkinson’s disease

    G. Agyeah, P. Antony, K. Wasner, A. Rakovic, S. Pereira, A. Grünewald (Esch-Sur-Alzette, Luxembourg)

    Objective: Our objective in this study was to elucidate the mechanisms underlying the release of mtDNA in cellular models of Parkin-associated Parkinson’s disease and to…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley